Siegesbeckia pubescens ameliorates experimental ulcerative colitis in rats by modulating PPARγ

被引：0
|
作者：
Teng, Tianli [1 ,3 ]
Xu, Shifang [1 ]
Chen, Qun [2 ]
Chen, Fengyang [1 ]
Li, Xiaoyu [1 ]
Gao, Lijuan [1 ]
Hao, Shujuan [1 ]
Ye, Yiping [1 ]
机构：
[1] Zhejiang Acad Med Sci, Inst Materia Med, Tianmushan Rd 182, Hangzhou 310013, Zhejiang, Peoples R China
[2] Ningbo Coll Hlth Sci, Ningbo 315100, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Pharm, Hangzhou 310003, Zhejiang, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2016年 / 9卷 / 12期
基金：
美国国家科学基金会;
关键词：
Siegesbeckia pubescens; ulcerative colitis; TNBS; PPAR gamma; ACTIVATED RECEPTOR-GAMMA; NF-KAPPA-B; INDUCED MODEL; ENT-KAURANE; INFLAMMATION; DITERPENOIDS; HETERODIMER; MACROPHAGES; MECHANISMS; EXPRESSION;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Siegesbeckia pubescens is a traditional Chinese medicine widely used for the treatment of inflammatory and autoimmune diseases in clinic. In order to evaluate its therapeutic effect against ulcerative colitis (UC) and elucidate its possible mechanisms, in this study, the effect of aqueous extract of S. pubescens (SPA) on 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced experimental UC in rats was determined. The results showed that oral administration of SPA significantly ameliorated colonic edema, hyperemia, inflammation and anabrosis in TNBS-induced experimental UC in rats. In addition, SPA inhibited MPO and pro-inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6 and IFN-gamma) production, and up-regulated PPAR. expression in colon. These results indicated that SPA has therapeutic effects against TNBS-induced experimental UC in rats, and its underlying mechanisms involve the modulation of PPAR gamma-mediated production of inflammatory mediators. These findings highlight the potential of this traditional Chinese medicine as an agent for use in the treatment of UC.
引用
收藏
页码：23082 / 23091
页数：10
相关论文
共 50 条
  • [21] The role of histamine in experimental ulcerative colitis in rats
    W. A. Fogel
    W. Wagner
    K. Sasiak
    A. Stasiak
    Inflammation Research, 2005, 54 : S68 - S69
  • [22] A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models
    Da Silva, Stephanie
    Keita, Asa V.
    Mohlin, Sofie
    Pahlman, Sven
    Theodorou, Vassilia
    Pahlman, Ingrid
    Mattson, Jan P.
    Soderholm, Johan D.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (04) : 792 - 805
  • [23] Intraperitoneal Administration of S100A8 Ameliorates Experimental Acute Colitis in Rats
    Matsuo, Kano
    Ikemoto, Masaki
    Okada, Kohki
    BIOLOGY-BASEL, 2024, 13 (11):
  • [24] Treatment with Mesna and n-3 polyunsaturated fatty acids ameliorates experimental ulcerative colitis in rats
    Triantafyllidis, Ioannis
    Poutahidis, Theofilos
    Taitzoglou, Ioannis
    Kesisoglou, Isaak
    Lazaridis, Charalampos
    Botsios, Dimitrios
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2015, 96 (06) : 433 - 443
  • [25] Involvement of PPAR in the protective action of tropisetron in an experimental model of ulcerative colitis
    Rahimian, Reza
    Zirak, Mohammad Reza
    Keshavarz, Mojtaba
    Fakhraei, Nahid
    Mohammadi-Farani, Ahmad
    Hamdi, Hanan
    Mousavizadeh, Kazem
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2016, 38 (06) : 432 - 440
  • [26] Sericic Acid Ameliorates DSS-induced Ulcerative Colitis in Mice by Modulating the NF-κB and Nrf2 Pathways
    Lifei-Luo
    Zhang, Jingze
    Li, Xinyu
    Zhu, Yanru
    Wang, Yansheng
    Liu, Dailin
    CURRENT MOLECULAR PHARMACOLOGY, 2023, 16 (07) : 759 - 770
  • [27] Keratinocyte growth factor gene therapy ameliorates ulcerative colitis in rats
    Chun-Jie Liu
    World Journal of Gastroenterology, 2011, 17 (21) : 2632 - 2640
  • [28] Therapeutic efficacy and mechanism of Zhenrenyangzang decoction in rats with experimental ulcerative colitis
    Wang, Hui
    Li, Shu-Hua
    Zhang, Yan
    Guan, Jie
    Wu, Yan-Min
    Wang, Qi
    Luo, Xiao-Qing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 15254 - 15261
  • [29] Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitis
    Guo, Ni
    Lv, Lu-lu
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (10)
  • [30] Astragaloside II alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo
    Qiao, Cuixia
    Wan, Jin'e
    Zhang, Lize
    Luo, Bo
    Liu, Penglin
    Di, Aiting
    Gao, Hairui
    Sun, Xiaomei
    Zhao, Gang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (11): : 7074 - 7083
12345